Standard cell panel screen - 2D OncoSignature™
Identify sensitive and resistant cell lines
- Pre-selected cancer cell lines (Horizon's library)
- Single therapeutic drug screening or combination drug screening
- Growth inhibition measure by ATP levels
We have updated the ordering process to allow all products and services to be purchased with a single PO, please address all POs to Horizon Discovery Biosciences Limited. Contact us for assistance.
Identify sensitive and resistant cell lines
Interview with Dr David Sorrell, Cell Panel Screening Manager, Horizon
Discussing the importance of efficacious screens to aiding patient stratification -
'Power up your pipeline: maximizing single & combination screening for cancer’
Use Horizon's screening services to identify sensitive or resistant cell lines to your drug
'Horizon's OncoSignature HT screening platform for the prediction of anticancer drug sensitivity'
We're here to support informed decision making by providing:
Isogenic cells are a powerful and relevant tool for therapeutic discovery and development.
View our results from: